This content is provided by Chambers. Learn more about our methodology
What the team is known for Advises on merger control in Russia relating to cross-border M&A deals and joint ventures. Regularly represents international clients in the energy, financial services, pharmaceutical and technology sectors.
Strengths Clients note the clarity of the team's advice, with a source reporting: "Their advice is timely and understandable."
Work highlights Assisted Mylan with the Russian merger clearance of its merger with Pfizer's Upjohn.
Evgeny Yuriev is a key contact at the practice.